APA (7th ed.) Citation

Byun, J. H., Lee, J., Park, K. H., Kang, E. J., Shin, S. J., Hwang, I. G., . . . Kim, E. Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Byun, Jae Ho, et al. Phase II Study of Nivolumab in Patients with Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers (KM-06). BMJ Publishing Group.

MLA (9th ed.) Citation

Byun, Jae Ho, et al. Phase II Study of Nivolumab in Patients with Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers (KM-06). BMJ Publishing Group.